NEUROONE MEDICAL TECHNOLOGIES Corp Cash And Cash Equivalents At Carrying Value

Quick Answer

NEUROONE MEDICAL TECHNOLOGIES Corp reported Cash And Cash Equivalents At Carrying Value of $6.57 million for the year ending 2025.

  • NEUROONE MEDICAL TECHNOLOGIES Corp showed an increase of +350.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from NEUROONE MEDICAL TECHNOLOGIES Corp's annual report (Form 10-K), filed with the SEC on December 17, 2025.
  • XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2017 to 2025), NEUROONE MEDICAL TECHNOLOGIES Corp's Cash And Cash Equivalents At Carrying Value has grown by 24,724.8%.
  • Historical annual values: Fiscal year 2025: $6.57 million | Fiscal year 2024: $1.46 million | Fiscal year 2023: $5.32 million | Fiscal year 2022: $8.16 million | Fiscal year 2021: $6.90 million | Fiscal year 2020: $4.04 million | Fiscal year 2019: $260.7 thousand | Fiscal year 2018: $13.3 thousand | Fiscal year 2017: $26.5 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: